UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction

The American heart journal, 1998-05, Vol.135 (5), p.825-832

1998

Volltextzugriff (PDF)

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1

European heart journal, 1999-12, Vol.20 (24), p.1799-1807

1999

Volltextzugriff (PDF)

Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure

European heart journal, 2007-07, Vol.28 (14), p.1723-1730

2007

Volltextzugriff (PDF)

Comparison of Neurohumoral Effects of Short-Acting and Long-Acting Loop Diuretics in Patients with Chronic Congestive Heart Failure

Journal of cardiovascular pharmacology, 2001-10, Vol.38 Suppl 1, p.S81-S85

2001

Volltextzugriff (PDF)

Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure

Circulation (New York, N.Y.), 2003-05, Vol.107 (20), p.2555-2558

2003

Volltextzugriff (PDF)

Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction

European heart journal, 2003-02, Vol.24 (4), p.346-355

2003

Volltextzugriff (PDF)

Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart Failure

Journal of the American College of Cardiology, 2006-02, Vol.47 (3), p.582-586

2006

Volltextzugriff (PDF)

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction

Circulation (New York, N.Y.), 2003-05, Vol.107 (20), p.2559-2565

2003

Volltextzugriff (PDF)

Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure

The American heart journal, 1997-11, Vol.134 (5), p.910-916

1997

Volltextzugriff (PDF)

Serum carvedilol concentration and its relation to change in plasma brain natriuretic peptide level in the treatment of heart failure: a preliminary study

International journal of clinical pharmacology and therapeutics, 2003-12, Vol.41 (12), p.578-586

2003

Volltextzugriff (PDF)

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure : Prognostic role of plasma brain natriuretic peptide concentration in Patients with chronic symptomatic left ventricular dysfunction

Circulation (New York, N.Y.), 1997-07, Vol.96 (2), p.509-516

1997

Volltextzugriff (PDF)

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Journal of the American College of Cardiology, 2000-11, Vol.36 (5), p.1587-1593

2000

Volltextzugriff (PDF)

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

Journal of the American College of Cardiology, 2001-04, Vol.37 (5), p.1228-1233

2001

Volltextzugriff (PDF)

Interleukin-6 Spillover in the Peripheral Circulation Increases With the Severity of Heart Failure, and the High Plasma Level of Interleukin-6 Is an Important Prognostic Predictor in Patients With Congestive Heart Failure

Journal of the American College of Cardiology, 1998-02, Vol.31 (2), p.391-398

1998

Volltextzugriff (PDF)

Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy

Journal of the American College of Cardiology, 2003-11, Vol.42 (9), p.1587-1593

2003

Volltextzugriff (PDF)

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

Journal of the American College of Cardiology, 2002-03, Vol.39 (6), p.957-962

2002

Volltextzugriff (PDF)

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

Journal of the American College of Cardiology, 2001-06, Vol.37 (7), p.1820-1826

2001

Volltextzugriff (PDF)

Proteomic Analysis Reveals Significant Alternations of Cardiac Small Heat Shock Protein Expression in Congestive Heart Failure

Journal of cardiac failure, 2006-02, Vol.12 (1), p.77-84

2006

Volltextzugriff (PDF)

Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP

American journal of physiology. Heart and circulatory physiology, 1997-05, Vol.272 (5), p.H2139-H2145

1997

Volltextzugriff (PDF)

Possible regulation of renin release by ANP in dogs with heart failure

American journal of physiology. Heart and circulatory physiology, 1995-06, Vol.268 (6), p.H2281-H2287

1995

Volltextzugriff (PDF)

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Journal of the American College of Cardiology, 2000-03, Vol.35 (3), p.714-721

2000

Volltextzugriff (PDF)

Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: Rationale, design, and preliminary data

The American heart journal, 2010-06, Vol.159 (6), p.949-955.e1

2010

Volltextzugriff (PDF)

NADPH Oxidase Inhibition in Heart Failure Improved Vascular Function Associated with Changes in the Novel Genes Expression Revealed by Transcriptome Analysis

Cardiovascular pharmacology: open access, 2017, Vol.6 (5)

2017

Volltextzugriff (PDF)

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

Journal of the American College of Cardiology, 2001-06, Vol.37 (8), p.2086-2092

2001

Volltextzugriff (PDF)

Angiotensin II Receptor Antagonist Improves the Immune Activations of Patients With Chronic Heart Failure

Journal of the American College of Cardiology, 1998-02, Vol.31 (2), p.33

Tsutamoto, T

1998

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(218)

Publikationsform

Artikel
(234)

Sprache

Englisch
(216)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(121)
Life Sciences & Biomedicine
(119)
Humans
(109)
Male
(104)
Cardiovascular System & Cardiology
(103)
Female
(101)
Cardiac & Cardiovascular Systems
(93)
Middle Aged
(90)
Aged
(72)
Biological And Medical Sciences
(62)
Medical Sciences
(61)
Natriuretic Peptide, Brain - Blood
(56)
Heart Failure - Blood
(55)
Heart Failure - Physiopathology
(51)
Heart Failure
(50)
Heart Failure - Drug Therapy
(48)
Heart
(42)
Cardiology. Vascular System
(41)
Adult
(39)
Atrial Natriuretic Factor - Blood
(37)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1

Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure

Comparison of Neurohumoral Effects of Short-Acting and Long-Acting Loop Diuretics in Patients with Chronic Congestive Heart Failure

Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure

Relationship between transcardiac gradient of endothelin-1 and left ventricular remodelling in patients with first anterior myocardial infarction

Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart Failure

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction

Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure

Serum carvedilol concentration and its relation to change in plasma brain natriuretic peptide level in the treatment of heart failure: a preliminary study

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure : Prognostic role of plasma brain natriuretic peptide concentration in Patients with chronic symptomatic left ventricular dysfunction

High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

Interleukin-6 Spillover in the Peripheral Circulation Increases With the Severity of Heart Failure, and the High Plasma Level of Interleukin-6 Is an Important Prognostic Predictor in Patients With Congestive Heart Failure

Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

Proteomic Analysis Reveals Significant Alternations of Cardiac Small Heat Shock Protein Expression in Congestive Heart Failure

Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP

Possible regulation of renin release by ANP in dogs with heart failure

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: Rationale, design, and preliminary data

NADPH Oxidase Inhibition in Heart Failure Improved Vascular Function Associated with Changes in the Novel Genes Expression Revealed by Transcriptome Analysis

Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy

Angiotensin II Receptor Antagonist Improves the Immune Activations of Patients With Chronic Heart Failure

Suchergebnisse filtern